CDSCO Flags 7 Batches of Popular Medicines as Purportedly Spurious in December
New Delhi: In a disclosure that raises serious concerns over drug authenticity and patient safety, the Central Drugs Standard Control Organisation (CDSCO) has flagged seven batches of commonly prescribed medicines as purportedly spurious following quality surveillance and authenticity checks conducted at central and state drug testing laboratories.
According to official data for December 2025, the medicines flagged as purportedly spurious include Chymoral Forte (Trypsin–Chymotrypsin Tablets) from batch numbers 2KU6L012 and 2KU6L045; Montina-L Tablets, containing Montelukast Sodium and Levocetirizine Hydrochloride (batch SPJ241236); Telma-AM, a combination of Telmisartan 40 mg and Amlodipine 5 mg Tablets (batch numbers 05241038A and 18240626); Telma 40 (Telmisartan Tablets IP 40 mg) from batch 18240413; and Pantop-D SR, comprising Pantoprazole Sodium gastro-resistant and Domperidone prolonged-release capsules (batch SPA250021).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.